Growth hormone, but not luteinizing hormone, acts with luteal peptides on prostaglandin F2alpha and progesterone secretion by bovine corpora lutea in vitro
- PMID: 11204740
- DOI: 10.1016/s0090-6980(00)00099-x
Growth hormone, but not luteinizing hormone, acts with luteal peptides on prostaglandin F2alpha and progesterone secretion by bovine corpora lutea in vitro
Abstract
Prostaglandin F2alpha (PGF2alpha) is a major physiological luteolysin in the cow. However, injection of PGF2alpha before day 5 (day 0 = estrus) of the estrous cycle dose not induce luteolysis. On the other hand, the early corpus luteum (CL) actively produces PGF2alpha. This indicates that luteal PGF2alpha may play a key role in the refractoriness to PGF2alpha injected during the early luteal phase when angiogenesis is active in the CL. Thus, this study aimed to investigate the possible interaction between pituitary hormones and local factors (luteal peptides) on secretion of PGF2alpha and progesterone (P) by the early bovine CL, and to evaluate the effect of growth hormone (GH) as well as its interactions on production of PGF2alpha in the developing CL. A RT-PCR analysis revealed that mRNA for GH receptor in CL was fully expressed from early in the luteal phase throughout the estrous cycle, while luteinizing hormone (LH) receptor mRNA was expressed less by the early and regressing CL than those at mid or late luteal phases (P < 0.05). For the stimulation test, an in vitro microdialysis system (MDS) was used as a model. Each bovine early CL (days 3-4) was implanted with the MDS, and maintained in an organ culture chamber. The infusion of GH, insulin-like growth factor-I (IGF-I) and oxytocin (OT) increased (P < 0.05) PGF2alpha and P release. In contrast, LH had no effect (P > 0.05) on PGF2alpha secretion and little effect on P release. Unexpectedly, there was no distinct interaction between pituitary hormones and luteal peptides on secretion of PGF2alpha and P. These results indicate that GH is a more powerful stimulator of PGF2alpha and P production in the early bovine CL than LH and suggest that GH and luteal peptides, IGF-1 and OT, contribute to maintenance of elevated PGF2alpha production in the developing bovine CL.
Similar articles
-
Sensitivity of bovine corpora lutea to prostaglandin F2alpha is dependent on progesterone, oxytocin, and prostaglandins.Biol Reprod. 1999 Jun;60(6):1292-8. doi: 10.1095/biolreprod60.6.1292. Biol Reprod. 1999. PMID: 10330083
-
Production and localisation of angiotensin II in the bovine early corpus luteum: a possible interaction with luteal angiogenic factors and prostaglandin F2 alpha.J Endocrinol. 2001 Aug;170(2):369-80. doi: 10.1677/joe.0.1700369. J Endocrinol. 2001. PMID: 11479133
-
Relative changes in mRNA expression of angiopoietins and receptors tie in bovine corpus luteum during estrous cycle and prostaglandin F2alpha-induced luteolysis: a possible mechanism for the initiation of luteal regression.J Reprod Dev. 2004 Dec;50(6):619-26. doi: 10.1262/jrd.50.619. J Reprod Dev. 2004. PMID: 15647613
-
Blood flow: a key regulatory component of corpus luteum function in the cow.Domest Anim Endocrinol. 2005 Aug;29(2):329-39. doi: 10.1016/j.domaniend.2005.03.011. Domest Anim Endocrinol. 2005. PMID: 15888379 Review.
-
Judge, jury and executioner: the auto-regulation of luteal function.Soc Reprod Fertil Suppl. 2007;64:191-206. doi: 10.5661/rdr-vi-191. Soc Reprod Fertil Suppl. 2007. PMID: 17491148 Review.
Cited by
-
Growth hormone in fertility and infertility: Mechanisms of action and clinical applications.Front Endocrinol (Lausanne). 2022 Nov 14;13:1040503. doi: 10.3389/fendo.2022.1040503. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36452322 Free PMC article. Review.
-
Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions.Int J Endocrinol. 2014;2014:234014. doi: 10.1155/2014/234014. Epub 2014 Dec 15. Int J Endocrinol. 2014. PMID: 25580121 Free PMC article. Review.
-
Prostaglandins in Superovulation Induced Bovine Follicles During the Preovulatory Period and Early Corpus Luteum.Front Endocrinol (Lausanne). 2019 Jul 10;10:467. doi: 10.3389/fendo.2019.00467. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31354631 Free PMC article.
-
Novel perspectives on growth hormone regulation of ovarian function: mechanisms, formulations, and therapeutic applications.Front Endocrinol (Lausanne). 2025 Apr 9;16:1576333. doi: 10.3389/fendo.2025.1576333. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40270715 Free PMC article. Review.
-
The role of growth hormone in assisted reproductive technology for patients with diminished ovarian reserve: from signaling pathways to clinical applications.Front Endocrinol (Lausanne). 2025 Apr 17;16:1551126. doi: 10.3389/fendo.2025.1551126. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40313485 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous